MMP-2: Expression, activation and inhibition

Enzyme and Protein

Volumn 49, Issue 1-3, 1996, Pages 7-19

  Corcoran, Marta L ^a   Hewitt, Robert E ^a   Kleiner Jr , David E ^a   Steuer Stevenson, William G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Activation; Gelatinase; Invasion; Metastasis

Indexed keywords

COLLAGENASE; ELASTASE; ENZYME PRECURSOR; GELATINASE; MESSENGER RNA; METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

CELL INVASION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GROWTH REGULATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0029999330     PISSN: 10196773     EISSN: None     Source Type: Journal    
DOI: 10.1159/000468613     Document Type: Review

References (79)

1. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
2. Sanchez-Lopez R, Alexander CM, Behrendtsen O, Breathnach R, Werb Z: Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. J Biol Chem 1993;268:7238-7247.
3. Strongin AY, Collier IE, Krasnov PA, Genrich LT, Marmer BL, Goldberg GI: Human 92 kD type IV collagenase: Functional analysis of fibronectin and carboxyl-end domains. Kidney Int 1993;43:158-162.
4. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-65.
5. Takino T. Hiroshi S. Yamamoto E, Seiki M: Cloning of a human gene potentially encoding a novel matrix metalloproteine having a C-terminal transmembrane domain. Gene 1994:155:293-298.
6. Will H, Hinzmann B: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995:231:602-608.
7. Takino T, Sato H. Shinagawa A. Seiki M: Identification of the second membrane-type matrix metalloproteinase gene from a human placenta cDNA library. MT-MMP form a unique membrane-type subclass in the MMP family. J Biol Chem 1995:270:23021-23030.
8. Nagase H. Barrett AJ, Woessner JF: Nomenclature and glossary of the matrix metalloproteinases, in BirkedalHansen H. Werb Z, Welgus HG. Van Wart HE (eds): Matrix Metalloproteinases and Inhibitors. Proceeding of the Matrix Metalloproteinase Conference, Sandestin Beach. Fla. Sept 11-15. 1989. New York. Fischer. 1992. pp 421-124.
9. Collier IE. Smith J. Kronberger A, Bauer EA. Wilhelm SM. Eisen AZ. Goldberg G1: The structure of the human skin fibroblast collagenase gene. J Biol Chem 1988:263:10711-10713.
10. Overall CM, Sodek J: Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase. 72-kD gelatinase. and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J Biol Chem 1990:265:21141-21151.
11. Brown PD. Levy AT, Margulies IM, Liotta LA. Stetler-Stevenson WG: Independent expression and cellular processing of M, 72.000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 1990:50:6184-6191.
12. Overall CM. Wrana JL. Sodek J: Transcriptional and post-transcriptional regulation of 72-kD gelatinase/type IV collagenase by transforming growth factor-beta-1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991:266:14064-14071.
13. Frisch S, Morisaki JH: Positive and negative transcriptional elements of the human type IV collagenase gene. Mol Cell Biol 1990:10:6524-6532.
14. Delany AM, Brinckerhoff CE: Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem 1992;50: 400-410.
15. Matrisian LM: Matrix metalloproteinase gene expression. Ann NY Acad Sei 1994:6:42-50.
16. Kerr LD, Miller DB. Matrisian LM: TGF-beta-1 inhibition of transin/stromelysin gene expression is mediated through a Fos-bindmg sequence. Cell 1990:61:267-278.
17. Shaw G, Kamen R: A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986:46:659-667.
18. Templeton NS, Stetler-Stevenson WG: Identification of a basal promoter for the human Mr 72.000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res 1991:51:6190-6193.
19. Wilhelm SM. Eisen AZ, Teter M. Clark SD, Kronenberger A. Goldberg G: Human fibroblast collagenase. Glvcosylation and tissue-specific level of enzyme synthesis. Proc Natl Acad Sei USA 1986:83:3756-3760.
20. Wilhelm SM, Collier IE. Kronberger A, Eisen AZ. Marmer BL. Grant GA. Bauer EA. Goldberg GI: Human skin fibroblast stromelysin: Structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sei USA 1987:84:6725-6729.
21. Van Wart H. Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sei USA 1990: 87:5578-5582.
22. Sanchez-Lopez R. Nicholson R. Gesnel M-C, Matrisian LM. Breathnach R: Structure-function relationships in the collagenase gene family member transin. J Biol Chem 1988:263:11892-11899.
23. Park AJ. Matrisian LM, Kells AF. Pearson R. Yuan ZY. Navre M: Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the 'cysteine switch'. J Biol Chem 1991:266:1584-1590.
24. Stetler-Stevenson WG, Talano JA, Gallagher ME, Krutzseh HC. Liotta LA: Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. Am J Med Sei 1991:302: 163-170.
25. Nomura K, Suzuki N: Stereo-specific inhibition of sea urchin envelysin (hatching enzyme) by a synthetic autoinhibitor peptide with a cysteine-switch consensus sequence. FEES Lett 1993:321:84-88.
26. Melchiori A. Albini A, Ray JM. Stetler-Stevenson WG: Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res 1992:52: 2353-2356.
27. Muir D: Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 1994:210:243-252.
28. Vassalli J-D, Sappino A-P. Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991:88: 1067-1072.
29. Werb Z, Mainardi CL. Vater C, Harris ED: Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. NEnglJMed 1977:296:1017-1023.
30. He C. Wilhelm SM, Pentland AP. Marmer BL, Grant GA, Eisen AZ, Goldberg GI: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sei USA 1989:86:2632-2636.
31. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y. Nakai N, Okada Y: Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995:270:6691-6697.
32. Fridman R, Toth M, Pena D, Mobashery S: Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 1995:55:2548-2555.
33. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi 1, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92-kD gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. J Biol Chem 1992; 267:21712-21719.
34. Menashi S, Fridman R, Desrevieres S, Lu H, Legrans Y, Soria C: Regulation of 92-kD gelationase B activity in the extracellular matrix by tissue kallikren. Ann N Y Acad Sei 1994;732:466-468.
35. Pei D, Weiss S: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995;375:244-247.
36. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG: Cellular activation of the 72-kD type IV procollagenaserriMP-2 complex. Kidney Int 1993;43:163-170.
37. Ward RV, Atkinson SJ, Slocombe PM, Docherty AJ, Reynolds JJ, Murphy G: Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72-kD progelatinase by fibroblast membranes. Biochim Biophys Acta 1991;1079:242-246.
38. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Docherty A: Regulation of matrix metalloproteinase activity. Ann N Y Acad Sei 1994;732:31-41.
39. Keski-Ojua J, Lohi J, Tuuttila A, Tryggvason K, Vartio T: Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992:202:471-76.
40. Ü Salo T, Liotta LA, Keski-Oja J, Turpeennieme-Hujanen T, Tryggvason K: Secretion of a basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - Role in metastasis. Int J Cancer 1982:30:669-673.
41. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990;194:721-730.
42. Strongin AY, Marmer BL, Grant GA, Goldberg GI: Plasma membrane-dependent activation of the 72-kD type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993;268:14033-14039.
43. Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJ: The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 1991;30: 8097-8102.
44. Cao J, Sato H, Takino T, Seiki M: The C-terminal region of membrane-type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 1995;270:801-805.
45. Emmert-Buck MR, Emonard HP, Corcoran ML, Krutzsch HC, Foidart J-M, Stetler-Stevenson WG: Cell surface binding of TIMP-2 and pro-MMP-2ATIMP-2 complex. FEES Lett 1995:364:28-32.
46. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kD type IV collagenase. J Biol Chem 1995;270:5331-5338.
47. Monsky WL, Kelly T, Lin CY, Yeh Y, Stetler-Stevenson WG, Mueller SC, Chen WT: Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res 1993:53:3159-3164.
48. Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta L, Stetler-Stevenson WG: Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 1994:145:1285-1290.
49. Okada A, Bellecq J-P, Rouyer N, Chenard M-P, Rio M-C, Chambon P, Besset P: Membrane-type matrix metalloproteinase gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sei USA 1995:90:2730-2734.
50. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR. Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985:318:66-69.
51. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase-2 (TIMP-2). J Biol Chem 1989;264:17374-17378.
52. DeClerck YA, Yean T-D, Ratzkin BJ, Lu HS, Langley KE: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 1989;264: 17445-17453.
53. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP: A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992;267:17321-17326.
54. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR: Tissue inhibitor of metalloproteinases-3 is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994:269:9352-9360.
55. Williamson RA, Marston FA, Angal S, Koklitis P, Panico M, Morris HR, Came AF, Smith BJ, Harris TJ, Freedman RB: Disulphide bond assignment in human tissue inhibitor of metalloproteinases, Biochem J 1990; 268:267-274.
56. DeClerck YA, Yean TD, Lee Y, Tomich JM, Langley KE: Characterization of the functional domain of tissue inhibitor of metalloproteinases-2. Biochem J 1993;289:65-69.
57. O'Shea M, Willenbrock F, Williamson RA, Cockett MI, Freedman RB, Reynolds JJ, Docherty AJ, Murphy G: Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1 : Importance of the N-terminal region between cysteine 3 and cysteine 13. Biochemistry 1992:31:10146-10152.
58. Bodden MK, Windsor LJ. Caterina NC. Yermovsky A, Birkedal-Hansen B. Galazka G, Engler JA. BirkedalHansen H: Analysis of the TIMP-1/FIB-CL complex. Ann N Y Acad Sei 1994;732:84-95.
59. Leco KJ, Hayden LJ. Sharma RR, Rocheleau H, Greenberg AH. Edwards DR: Differential regulation of TIMP-1 and TIMP-2 messenger RNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene 1992; 117:209-217.
60. Stetler-Stevenson WG. Brown PD. Onisto M. Levy AT. Liotta LA: Tissue inhibitor of metalloproteinases-2 mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990;265:13933-13938.
61. Kleiner D Jr. Unsworth EJ. Krutzsch HC, Stetler-Stevenson WG: Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. Biochemistry 1992:31: 1665-1672.
62. Fridman R. Fuerst TR. Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D. Liotta LA, Berman ML, Stetler-Stevenson WG: Domain structure of human 72-kD gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 binding regions. J Biol Chem 1992:267:15398-15405.
63. Kleiner DE Jr. Tuuttla A, Tryggvason K, Stetler-Stevenson WG: Stability analysis of latent and active 72-kD type IV collagenase: The role of tissue inhibitor of metalloproteinases~2. Biochemistry 1993:32:1583-1592.
64. Gasson JC. Golde DW. Kaufman SE, Westbrook ÇA, Hewick RM. Kaufman RJ, Wong GO. Temple PA. Leary AC. Brown EL. Orr EC. Clark SC: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985:315:768-771.
65. Stetler-Stevenson WG, Bersch N. Golde DW: Tissue inhibitor of metalloproteinase-2 has erythroid-potentiating activity. FEES Lett 1992;296:231-234.
66. Hayakawa T, Yamashita K, Tanzawa K. Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1, for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992:298: 29-32.
67. Bertaux B, Hornebeck W. Eisen AZ. Dubertret L: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 1991 ;97:679-685.
68. Boujrad N, Ogwuegbu SO. Gamier M. Lee C-H. Martin BM. Vassilios BM. Papadopoulos V: Identification of a stimulator of steroid hormone synthesis isolated from testes. Science 1995:268:1609-1612.
69. Agrez MV, Meldrum CJ. Sim ATR. Aebersold RH. Clark IM, Cawson TE, Burns OF: A fibroblast elongation factor purified from colon carcinoma cells shares sequence homology with TIMP-I. Biochem Biophys Res Commun 1995:206:590-600.
70. Nemeth JA, Goolsby CL: TIMP-2. a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp Cell Res 1993:207:376-382.
71. Matsumoto H, Ishibashi Y, Ohtaki T. Hasegawa Y. Koyama C. Inoue K: Newly established murine pituitary folliculo-stellate-like cell line (TtT/GF) secretes potent pituitary glandular cell survival factors, one of which corresponds to metalloproteinase inhibitor. Biochem Biophys Res Commun 1993;194:909-915.
72. Hayakawa T. Yamashita K, Ohuchi E, Shinagawa A: Cell-promoting activity of tissue inhibitor of metalloproteinases-2. J Cell Sei 1994; 107:2373-2379.
73. Corcoran ML, Stetler-Stevenson WG: Tissue inhibitor of metalloproteinase-2 stimulates fibroblasts proliferation via a cAMP-dependent mechanism. J Biol Chem 1994;270:13453-13459.
74. Albini A, Melchiori A, Santi L. Liotta LA, Brown PD, Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2 (see comments). J Nail Cancer Inst 1991:83:775-779.
75. Tanaka K. Iwamoto Y. Ito Y, Ishbashi T, Nakabeppu Y, Sekiguchi M. Sugioka Y: Cyclic AMP resulted synthesis of the tissue inhibitors of metalloproteinase suppresses the invasive potential of human fibrosarcoma cell line HT1080. Cancer Res 1995:55:2927-2935.
76. Okuyama K, Iwamoto Y, Tanaka K, Ito Y, Sugioka Y: The inhibition of the invasion of human fibrosarcoma cells by cyclic AMP analogues and cholera toxin. Cancer J 1994;7:150-157.
77. Murphy AN, Unsworth EJ, Stetler-Stevenson WG: Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993:157:351-358.
78. Albini A, Fontanini G. Masiallo L, Tacchetti C, Bigini D, Lizzi P, Noonan D, Stetler-Stevenson WG: Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KSlike leasions by tissue inhibitor of metalloproteinase-2. AIDS 1994;8:1237-1244.
79. Ohba Y, Goto Y. Kimura Y, Suzuki F, Hisa T. Takahashi K, Takigawa M: Purification of an angiogenesis inhibitor from culture-medium conditioned by a human chondrosarcoma-derived chondrocytic cell-line HCS-28. Biochim Biophys Acta 1995:1245:1-8.